Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Lung Diseases(Electronic Edition) ›› 2025, Vol. 18 ›› Issue (03): 401-405. doi: 10.3877/cma.j.issn.1674-6902.2025.03.011

• Original articles • Previous Articles    

Clinical research of serum soluble growth stimulation expressed gene 2 and the risk of acute pulmonary embolism complicated with pulmonary hypertension

Wendeng Chen1, Min Chen2, Shuxiang Wu3, Xiangzhen Zheng1, Bin Chen1, Liutong Chen1,()   

  1. 1. Department of Respiratory Medicine,Southeast Hospital Affiliated to Xiamen University,909th Hospital,Xiamen 363000,China
    2. Department of Radiology,Hua'an County Hospital,Zhangzhou 363800,China
    3. Zhangzhou Fourth Hospital,Zhangzhou 363000,China
  • Received:2025-03-03 Online:2025-06-25 Published:2025-07-17
  • Contact: Liutong Chen

Abstract:

Objective

To analyze the correlation between serum soluble growth stimulation expressed gene 2 protein (sST-2) and the risk of pulmonary hypertension complicating acute pulmonary embolism(APE).

Methods

Seventy-two APE patients treated in our hospital from January 2021 to January 2024 were selected. Sixteen patients with concurrent pulmonary hypertension were assigned to the observation group,and 56 patients without pulmonary hypertension served as the control group. General data,serum sST-2 levels,forced expiratory volume in one second (FEV1),interleukin-6 (IL-6),red cell distribution width (RDW),and mean platelet volume (MPV) were compared between the two groups. Logistic regression was used to analyze influencing factors of pulmonary hypertension in APE patients. The predictive value of these factors for pulmonary hypertension in APE patients was assessed using receiver operating characteristic (ROC) curves.

Results

The FEV1 of the observation group was (52.78±5.33)L,lower than that of the control group (58.25±6.35)L. The serum sST-2 (133.15±8.34)ng/ml,IL-6 (56.83±5.88)mg/ml,RDW(15.64±3.67)%,and D-dimer (3.13±0.77) mg/L of the observation group were higher than those of the control group sST-2 (122.62±5.77)ng/ml,IL-6 (51.57±1.36)mg/ml,RDW (12.72±1.48)%,D-dimer (2.82±0.32)mg/L (P<0.05).Logistic regression analysis showed that high serum sST-2 (OR=1.613,95% CI:1.043~2.493),IL-6(OR=3.002,95% CI:1.276~7.060),and RDW (OR=4.029,95% CI:1.135~14.305) were risk factors for acute pulmonary embolism (APE)-related pulmonary hypertension,while FEV1OR= 0.692,95% CI:0.484 ~0.988) was a protective factor (P<0.05). Receiver operating characteristic (ROC) curve results showed that the area under the curve (AUC) of FEV1,serum sST-2,IL-6,and RDW for diagnosing APE-related pulmonary hypertension were 0.733,0.853,0.828,and 0.771,respectively (P<0.05).

Conclusion

FEV1,serum sST-2,IL-6,and RDW are influencing factors for pulmonary hypertension complicating APE,and serum sST-2 can predict the occurrence of pulmonary hypertension in APE patients.

Key words: Acute pulmonary embolism, Pulmonary hypertension, D-dimer, Soluble growth stimulation expressed gene 2 protein, Forced expiratory volume in one second, Red cell distribution width

京ICP 备07035254号-28
Copyright © Chinese Journal of Lung Diseases(Electronic Edition), All Rights Reserved.
Tel: 023-65425691 E-mail: xqcjld@163.com
Powered by Beijing Magtech Co. Ltd